Bevacizumab-IRDye800CW
Sponsors
University Medical Center Groningen, Technical University of Munich
Conditions
Adenomatous Polyposis ColiAge-Related Macular DegenerationBarrett EsophagusBreast CancerDysplasiaEsophageal CancerHilar CholangiocarcinomaNAMD
Phase 1
VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer
CompletedNCT01508572
Start: 2011-10-31End: 2015-01-31Updated: 2017-10-27
Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer
CompletedNCT01972373
Start: 2013-10-31End: 2017-01-31Updated: 2024-04-16
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
CompletedNCT02113202
Start: 2014-03-31End: 2015-10-31Updated: 2023-10-27
VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions
CompletedNCT02129933
Start: 2014-04-30End: 2016-11-30Updated: 2024-04-16
Fluorescence Endoscopy of Esophageal Carcinoma
TerminatedNCT03558724
Start: 2018-10-29End: 2022-10-11Updated: 2024-04-16
Fluorescence Image Guided Surgery in Cholangiocarcinoma
NCT03620292
Start: 2019-04-01End: 2021-12-01Target: 12Updated: 2021-04-28
FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW
CompletedNCT03913806
Start: 2018-05-01End: 2020-01-01Updated: 2020-01-28
Detection of PitNET Tissue During TSS Using Bevacizumab-800CW
CompletedNCT04212793
Start: 2020-10-28End: 2022-10-24Updated: 2023-04-14
Targeted Fluorescence Imaging in AMD
CompletedNCT05262244
Start: 2022-10-28End: 2024-03-30Updated: 2024-12-06
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW
CompletedNCT06095362
Start: 2021-11-29End: 2023-10-12Updated: 2024-08-22
Phase 2
Detection of Early Esophageal Cancer by NIR-FME.
NCT03877601
Start: 2019-07-29End: 2021-10-01Target: 60Updated: 2020-11-04
Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW
WithdrawnNCT05359874
Start: 2021-06-30End: 2023-03-31Updated: 2022-05-04